Foghorn Therapeutics
$11.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$11.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.28 (-2.38%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell FHTX and other stocks, options, and ETFs commission-free!
About FHTX
Foghorn Therapeutics Inc. Common Stock, also called Foghorn Therapeutics, is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology.
CEO
Adrian Gottschalk
Employees
95
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
438.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
50.06K
High Today
$12.05
Low Today
$11.20
Open Price
$11.89
Volume
50.38K
52 Week High
$28.27
52 Week Low
$11.20
FHTX Earnings
-$3.12
-$1.24
$0.65
$2.53
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours